Alpha Cognition Inc

자세한 내용은 Alpha Cognition Inc 회사

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.

회사 정보

종목 코드 ACOG

회사 이름Alpha Cognition Inc

상장일Jun 09, 2021

CEOMr. Michael Mcfadden

직원 수52

유형Ordinary Share

회계 연도 종료Jun 09

주소c/o 1200 - 750 West Pender Street

도시VANCOUVER

증권 거래소NASDAQ Capital Market Consolidated

국가Canada

우편 번호V6C 2T8

전화16045649244

웹사이트https://www.alphacognition.com/

종목 코드 ACOG

상장일Jun 09, 2021

CEOMr. Michael Mcfadden

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Len Mertz

Independent Chairman of the Board

324.01K

+44.95%

Mr. Michael Mcfadden

Chief Executive Officer, Director

14.14K

+22.61%

Dr. Robert Wills

Independent Director

--

Mr. Henry Du

Interim Chief Financial Officer, Vice President - Finance and Accounting

--

Ms. Lauren D'Angelo

Chief Operating Officer

--

Mr. Kenneth A. (Ken) Cawkell

Corporate Secretary, Director

--

Mr. Rajeev (Rob) Bakshi

Independent Director

--

Mr. John Havens

Independent Director

--

Mr. Phillip Mertz

Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Mr. Len Mertz

Independent Chairman of the Board

324.01K

+44.95%

Mr. Michael Mcfadden

Chief Executive Officer, Director

14.14K

+22.61%

Dr. Robert Wills

Independent Director

--

Mr. Henry Du

Interim Chief Financial Officer, Vice President - Finance and Accounting

--

Ms. Lauren D'Angelo

Chief Operating Officer

--

Mr. Kenneth A. (Ken) Cawkell

Corporate Secretary, Director

--

수익 분석

데이터 없음

데이터 없음

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Mon, Jun 2

주주

주주 유형

주주

비율

Solas Capital Management, LLC

8.70%

AWM Investment Company, Inc.

6.84%

Besser (James E)

6.26%

Ikarian Capital LLC

6.04%

Cable Car Capital LLC

5.42%

Other

66.74%

주주

비율

Solas Capital Management, LLC

8.70%

AWM Investment Company, Inc.

6.84%

Besser (James E)

6.26%

Ikarian Capital LLC

6.04%

Cable Car Capital LLC

5.42%

Other

66.74%

주주 유형

주주

비율

Hedge Fund

24.50%

Investment Advisor/Hedge Fund

15.12%

Individual Investor

13.17%

Investment Advisor

2.03%

Bank and Trust

0.07%

Other

45.11%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

35

8.79M

54.89%

+876.51K

2025Q1

38

8.25M

51.64%

+1.18M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Solas Capital Management, LLC

1.39M

8.7%

--

Mar 31, 2025

AWM Investment Company, Inc.

1.10M

6.84%

+42.17K

+4.00%

Mar 31, 2025

Besser (James E)

1.00M

6.26%

+1.00M

--

Jan 15, 2025

Ikarian Capital LLC

967.87K

6.04%

+212.00K

+28.05%

Mar 31, 2025

Cable Car Capital LLC

868.45K

5.42%

+353.72K

+68.72%

Apr 09, 2025

Sphera Funds Management Ltd.

596.99K

3.73%

-23.01K

-3.71%

Mar 31, 2025

Cawkell (Kenneth Anthony)

358.12K

2.24%

+139.64K

+63.92%

Apr 22, 2025

Alyeska Investment Group, L.P.

337.47K

2.11%

-62.53K

-15.63%

Mar 31, 2025

Mertz (Len)

324.01K

2.02%

+100.48K

+44.95%

Apr 22, 2025

Havens (John P)

285.59K

1.78%

--

Apr 22, 2025

8.500USD

Alpha Cognition Inc

8.500

개요

회사

금융